PharMerica’s Onco360 Selected as Exclusive Specialty Pharmacy Partner for UKONIQ

PharMerica is a leading provider of home and community-based health and pharmacy services for high-need and medically complex populations

Centene’s Restructuring Initiative Focuses on Behavioral Health and Pharmacy Growth

Centene’s recent acquisition of PANTHERx will play a major role in the company’s specialty pharmacy growth

The Ensign Group Plans to Capitalize On The Value of its Owned Real Estate

Ensign’s independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, at 231 healthcare facilities and approximately 23,000 skilled nursing beds

PBM Capital Rx Plans to Accelerate Growth with $50 Million Investment

Through its Clearinghouse Model, Capital Rx unlocks the pharmacy supply chain and reduces prescription costs for employer groups

Humana Joins Cigna’s Drug Buying Group Ascent Health Services

Ascent Health manages commercial rebates, the payments that drug makers make to health plans

Optum Frontier Therapies Launched to Focus on Cell and Gene Therapy

Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics

Shields Acquires Excelera Shining Spotlight on Health System Specialty Pharmacies

Since 2015, the prevalence of health system-owned specialty pharmacies in large hospitals has doubled, with nearly 90 percent of large hospitals operating a specialty pharmacy in 2019

CareMetx’s Private Equity Investments to Accelerate Company’s Growth

Recently, CareMetx started a new division, OutcomeRx, to focus on holistic solutions for  biotech companies to address the patient, manufacturer, and payer challenges in the evolving Cell and Gene Therapy (CGT) market